Trials / Completed
CompletedNCT01000766
Identifying Changes in Blood (Potential Biomarkers) in Individuals With Drug-Induced Liver Injury
Identification of New Biomarkers of Drug Induced Liver Injury
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (actual)
- Sponsor
- University of North Carolina, Chapel Hill · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver.
Detailed description
Our hypothesis is that there are liver-specific particles, called mRNA, that are identifiable in a person's blood sample during liver injury caused by some drugs. The purpose of this study is to try to develop new blood tests that may help doctors identify if a drug is hurting a person's liver, perhaps early in the process before significant injury or illness have occurred.
Conditions
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2013-12-01
- Completion
- 2013-12-01
- First posted
- 2009-10-23
- Last updated
- 2017-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01000766. Inclusion in this directory is not an endorsement.